Next Science Limited 

$0
2
-$0.02-93.75% Tuesday 14:32

Statistics

Day High
0.02
Day Low
0.02
52W High
0.11
52W Low
0
Volume
20,000
Avg. Volume
4,011
Mkt Cap
0
P/E Ratio
-
Dividend Yield
10,182%
Dividend
0.1

Upcoming

Dividends

10,182%Dividend Yield
Feb 26
$0.1
Feb 26
$0.1
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

4MarExpected
Q4 2021
Q2 2022
Q4 2023
Q2 2024
Q4 2024
Q2 2025
Q4 2025
-0.03
-0.02
-0.02
-0.02
Expected EPS
N/A
Actual EPS
N/A

Financials

-46.4%Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
45.63MRevenue
-21.17MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NXSCF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the surgical products sector, offering solutions that can overlap with Next Science's infection prevention technologies.
Stryker
SYK
Mkt Cap136.19B
Stryker Corporation specializes in medical technologies, including surgical equipment and orthopaedic devices, competing in the same space as Next Science.
Medtronic
MDT
Mkt Cap116.33B
Medtronic plc provides medical technologies, services, and solutions, including those for surgical wound management, directly competing with Next Science's offerings.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, Inc. offers robotic-assisted surgical systems, potentially reducing the need for traditional surgical infection control products like those from Next Science.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the medical devices segment, offering a broad range of products that compete with Next Science's surgical infection prevention solutions.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific Corporation develops medical devices that are used in various surgical procedures, competing with Next Science's technology in infection management.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers medical devices and healthcare solutions that can compete with Next Science's products in the areas of wound care and surgical recovery.
Baxter International
BAX
Mkt Cap9.49B
Baxter International Inc. provides a portfolio of healthcare products, including hospital and surgical products, which compete with Next Science's infection prevention technologies.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences Corporation specializes in heart and critical care products, which can overlap with Next Science's focus on surgical site infections.
Hologic
HOLX
Mkt Cap16.45B
Hologic, Inc. focuses on women's health and surgical products, competing in the same niche as Next Science with products aimed at reducing surgical complications.

About

Next Science Limited, a medical technology company, researches, develops, and commercializes technologies that address the impacts of biofilms in human health in the United States and Australia. The company develops its products using Xbio Technology platform. It offers SURGX, an antimicrobial gel designed for surgical infection management; BACTISURE, a wound lavage that is used to remove biofilm; BlastX, an antimicrobial wound gel that destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment; and XPERIENCE, an no rinse antimicrobial solution that helps prevent surgical site infections. Next Science Limited was founded in 2012 and is headquartered in Chatswood, Australia.
Show more...
CEO
Mr. Harry Thomas Hall
Country
AU

Listings

0 Comments

Share your thoughts

FAQ

What is Next Science Limited stock price today?
The current price of NXSCF is $0 USD — it has decreased by -93.75% in the past 24 hours. Watch Next Science Limited stock price performance more closely on the chart.
What is Next Science Limited stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Next Science Limited stocks are traded under the ticker NXSCF.
Is Next Science Limited stock price growing?
NXSCF stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Next Science Limited has showed a -98% decrease.
What is Next Science Limited revenue for the last year?
Next Science Limited revenue for the last year amounts to 45.63M USD.
What is Next Science Limited net income for the last year?
NXSCF net income for the last year is -21.17M USD.
Does Next Science Limited pay dividends?
Yes, NXSCF dividends are paid en. The last dividend per share was 0.1 USD. As of today, Dividend Yield (FWD)% is 10,182%.
In which sector is Next Science Limited located?
Next Science Limited operates in the Health Care sector.
When did Next Science Limited complete a stock split?
Next Science Limited has not had any recent stock splits.
Where is Next Science Limited headquartered?
Next Science Limited is headquartered in Sydney, AU.